Author:
Gerke Sara,Hansen Solveig Lena
Publisher
Springer Berlin Heidelberg
Reference36 articles.
1. AMED = Japan Agency for Medical Research and Development (2018) The World’s First Allogeneic iPS-derived Retina Cell Transplant.
https://www.amed.go.jp/en/seika/fy2018-05.html
. Zugegriffen am 16.01.2020
2. Concannon TW, Meissner P, Grunbaum JA, McElwee N, Guise J, Santa J, Conway PH, Daudelin D, Morrato EH, Leslie LK (2012) A new taxonomy for stakeholder engagement in patient-centered outcomes research. J Gen Intern Med 27:985–991
3. Crocker JC, Ricci-Cabello I, Parker A, Hirst JA, Chant A, Petit-Zeman S, Evans D, Rees S (2018) Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis. BMJ 363:k4738
4. Cynata Therapeutics (2019) Graft-versus-host-disease.
https://www.cynata.com/graftversushostdisease
. Zugegriffen am 16.01.2020
5. Cyranoski D (2018) ‚Reprogrammed‘ stem cells implanted into patient with Parkinson’s disease. Nature.
https://www.nature.com/articles/d41586-018-07407-9
. Zugegriffen am 16.01.2020